A powerful partnership of clinicians, scientists, and universities working in cooperation with experienced business professionals and technology-focussed investors.
Cell Medica is a partnership of clinicians, scientists, universities, and investors working together to make the unique benefits of T cell immunotherapy available to patients on a routine basis rather than being confined to a few research hospitals in a clinical trial setting.
Cell Medica’s research partners include the Royal Free Hospital, University College London, Imperial College London, and the University of Würzburg.